Evidence map›Paper›PMID 35631017›Full record

ArticlePathogens (Basel, Switzerland)2022

Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders.

Stefka Krumova, Ivona Andonova, Radostina Stefanova, Polina Miteva, Galina Nenkova, Judith M Hübschen

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Stefka KrumovaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.
Ivona AndonovaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.
Radostina StefanovaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1233 Sofia, Bulgaria.
Polina MitevaSpecialized Hospital for Active Treatment of Children's Diseases "Prof. Dr. Ivan Mitev" EAD, 1612 Sofia, Bulgaria.
Galina NenkovaDepartment of Biology, Medical University, 9002 Varna, Bulgaria.
Judith M HübschenClinical and Applied Virology Group, Department of Infection and Immunity, Luxembourg Institute of Health, 4354 Esch-sur-Alzette, Luxembourg.ORCID 0000-0002-5001-2128
National Center of Infectious and Parasitic Diseases · BGLuxembourg Institute of Health · LUMedical University of Varna · BGSpecialized Hospital for Active Treatment of Children's Diseases · BG

Funding

European Regional Development Fund through Operational Program Science and Education for Smart Growth 2014-2020 BG05M2OP001-1.002-0001-C04
6 · The paper itself

Abstract

Primate erythroparvovirus 1, commonly referred to as Parvovirus B19 (B19V), is a DNA virus that normally results in a mild childhood infection called "erythema infectiosum". Besides respiratory spread, B19V can also be transmitted through transfusions, which may result in persistent anemia in immunodeficient hosts. Dialysis patients often face acute or chronic anemia after infection with B19V. Here, we describe the laboratory investigation of 21 patients with hematological disorders for B19V infections. B19V DNA was detected in 13 (62%) of them, with specific IgM antibodies in three of the DNA positives. All 13 patients received treatment and were laboratory-monitored over a period of one year. In only two patients (a 14-year-old child with a kidney transplantation and a 39-year-old patient with aplastic anemia), markers of recent B19V infection were still detectable in follow-up samples. For four B19V DNA positive samples, short sequences could be obtained, which clustered with genotype 1a reference strains. Our findings suggest that all cases of hematological disorders should be examined for specific B19V antibodies and DNA for accurate diagnosis and appropriate patient management.

Indexed as

anemiaIgM antibodieskidney recipientsParvovirus B19 (B19V)viral DNA

Identifiers

PMID35631017
PMCPMC9143349
OpenAlexW4224308145

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.